Article Versions Notes

de Koning L, Decaudin D, El Botty R, Nicolas A, Carita G, Schuller M, Ouine B, Cartier A, Naguez A, Fleury J, et al. PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma. Cancers. 2019; 11(6):751. https://doi.org/10.3390/cancers11060751

de Koning, Leanne, Didier Decaudin, Rania El Botty, André Nicolas, Guillaume Carita, Mathieu Schuller, Bérengère Ouine, Aurélie Cartier, Adnan Naguez, Justine Fleury, and et al. 2019. "PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma" Cancers 11, no. 6: 751. https://doi.org/10.3390/cancers11060751

de Koning, L., Decaudin, D., El Botty, R., Nicolas, A., Carita, G., Schuller, M., Ouine, B., Cartier, A., Naguez, A., Fleury, J., Cooke, V., Wylie, A., Smith, P., Marangoni, E., Gentien, D., Meseure, D., Mariani, P., Cassoux, N., Piperno-Neumann, S., ... Némati, F. (2019). PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma. Cancers, 11(6), 751. https://doi.org/10.3390/cancers11060751